eanNews
  • EAN News
    • All Executive Page President’s Corner EAN News EAN Congress news Interviews
      President’s Corner

      President’s Corner – October 2025

      October 8, 2025

      Research Highlights

      Research Highlights of the Month – October 2025

      October 7, 2025

      Paper of the Month

      Research Paper of the Month: AI-driven reclassification of multiple sclerosis progression

      October 6, 2025

      EAN News

      Join now for bonus months! Plus: October renewal discount and special benefit for associate members 

      October 1, 2025

      Executive Page

      Executive Page: New Opportunities and Resources to Strengthen EAN’s Scientific Community in 2025–2026

      September 4, 2025

      Executive Page

      Executive Page: the RRFS is here to support you – and help shape the future of European neurology

      August 12, 2025

      Executive Page

      Executive Page: thank you for making the EAN Congress 2025 a great success!

      July 16, 2025

      Executive Page

      Executive Page: Get ready for EAN 2025 in Helsinki!

      June 3, 2025

      President’s Corner

      President’s Corner – October 2025

      October 8, 2025

      President’s Corner

      President’s Corner – September 2025

      September 4, 2025

      President’s Corner

      President’s Corner – August 2025

      August 12, 2025

      President’s Corner

      President’s Corner – July 2025

      July 16, 2025

      EAN News

      President’s Corner – October 2025

      October 8, 2025

      EAN News

      Research Highlights of the Month – October 2025

      October 7, 2025

      EAN News

      Research Paper of the Month: AI-driven reclassification of multiple sclerosis progression

      October 6, 2025

      EAN News

      Join now for bonus months! Plus: October renewal discount and special benefit for associate members 

      October 1, 2025

      EAN Congress news

      EAN Associate Members get access to EAN Congress 2025 content for October!

      September 26, 2025

      EAN Congress news

      Save the Dates: EAN Congress 2026 in Geneva, Switzerland, 27-30 June

      September 10, 2025

      EAN Congress news

      An EAN Student Member’s experience at the EAN Congress – Helsinki 2025

      September 1, 2025

      EAN Congress news

      A Congress Highlight in Helsinki: Brain Health and Sustainability Booth

      August 28, 2025

      Interviews

      Video Interview: Mood Alterations in the Prodromal Phase of Sporadic Creutzfeldt-Jakob Disease, with Raphael Wurm

      March 14, 2025

      Interviews

      Video Interview: EMA approval of lecanemab, with Sebastiaan Engelborghs, EAN Dementia Panel Co-Chair

      January 15, 2025

      Interviews

      Video interview: Claudia Sommer, incoming Editor-in-Chief of the European Journal of Neurology

      January 3, 2025

      Interviews

      Video interviews: meet some of the EAN’s national neurological society partners!

      November 20, 2024

  • Research
    • All Paper of the Month Research Highlights Research Funding
      Research

      EMA Neurology News – September 2025

      October 8, 2025

      Research Highlights

      Research Highlights of the Month – October 2025

      October 7, 2025

      Paper of the Month

      Research Paper of the Month: AI-driven reclassification of multiple sclerosis progression

      October 6, 2025

      Research Highlights

      Research Highlights of the Month – September 2025

      September 10, 2025

      Paper of the Month

      Research Paper of the Month: AI-driven reclassification of multiple sclerosis progression

      October 6, 2025

      Paper of the Month

      Research Paper of the Month: Lithium deficiency and the onset of Alzheimer’s disease

      September 4, 2025

      Paper of the Month

      Research Paper of the Month: Higher Educational Attainment and Accelerated Tau Accumulation in Alzheimer Disease

      August 12, 2025

      Paper of the Month

      Research Paper of the Month: Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation (CATALYST)

      July 16, 2025

      Research Highlights

      Research Highlights of the Month – October 2025

      October 7, 2025

      Research Highlights

      Research Highlights of the Month – September 2025

      September 10, 2025

      Research Highlights

      Research Highlights of the Month – August 2025

      August 12, 2025

      Research Highlights

      Research Highlights of the Month – July 2025

      July 16, 2025

      Research Funding

      Draft Innovative Health Initiative (IHI) Funding Call topics related to the brain

      May 2, 2025

      Research Funding 'Horizon Europe' in large 3D text, surrounded by illustrations of people undertaking various activities

      Upcoming Horizon Europe Funding Opportunities for Neurology Researchers (Draft Calls)

      May 2, 2025

  • Education
    • All eLearning Mid-Career Resident and Research Fellows Student Corner Fellowship reports
      eLearning

      More webinars and brand-new episodes of eanCast: Weekly Neurology in October!

      October 7, 2025

      eLearning

      Join us for all-new Webinars in September!

      September 2, 2025

      EAN Congress news

      An EAN Student Member’s experience at the EAN Congress – Helsinki 2025

      September 1, 2025

      EAN News

      Shape the Future of EAN Panels – Apply to Join a Panel Management Group!

      September 1, 2025

      eLearning

      More webinars and brand-new episodes of eanCast: Weekly Neurology in October!

      October 7, 2025

      eLearning

      Join us for all-new Webinars in September!

      September 2, 2025

      eLearning

      Join our Webinar on New challenges in Myasthenia Gravis in the Era of Innovative Treatments

      August 28, 2025

      eLearning

      Join our Webinar on Multidisciplinary Perspectives on aTTR Amyloidosis: From Nerves to Heart

      August 21, 2025

      Mid-Career

      Certificate of Advanced Studies (CAS) in Brain Health starts second round in January 2026

      August 25, 2025

      Mid-Career

      First 20 EAN Leadership Programme participants graduate, as second group gets underway

      July 10, 2025

      Mid-Career

      Empowering growth: my journey through the EAN Leadership Programme

      March 14, 2025

      Mid-Career

      Join the EAN Congress Masterclass in Vienna!

      January 20, 2025

      Resident and Research Fellows

      Shape the Future of EAN Panels – Apply to Join a Panel Management Group!

      September 1, 2025

      Resident and Research Fellows

      Sign up for the 5th EAN Science School, 13-17 March, 2026

      August 20, 2025

      Resident and Research Fellows

      EAN Regional Teaching Day in Riga, Latvia – 6 November 2025

      August 13, 2025

      Resident and Research Fellows

      Executive Page: the RRFS is here to support you – and help shape the future of European neurology

      August 12, 2025

      Student Corner

      An EAN Student Member’s experience at the EAN Congress – Helsinki 2025

      September 1, 2025

      Student Corner

      Student Teaser Fellowships winners 2025

      June 6, 2025

      Student Corner Photo of a sheet of paper, pencil and crumpled paper on a desk.

      Why Neurology? Read some compelling answers from our EAN 2025 essay contest winners!

      May 12, 2025

      Student Corner

      Student Teaser Fellowship reports 2023 – Paris & Basel

      March 12, 2025

      Fellowship reports

      Research Fellowship Reports 2023: Lyon, Berlin, & London

      March 31, 2025

      Fellowship reports

      Student Teaser Fellowship reports 2023 – Paris & Basel

      March 12, 2025

      Fellowship reports

      Clinical Fellowship Reports 2023: Utrecht, Dianalund, & London

      February 20, 2025

      Fellowship reports

      Research Fellowship Reports 2023: London & Vienna/Paris

      October 8, 2024

  • Other News
    • All EAN Staff EBC News in general Surveys
      Advocacy

      Why do Placebo and Nocebo Effects Matter? – Improving the Education of Healthcare Professionals | 5 November 2025

      August 21, 2025

      Other News

      EAN Panel Management Group Member Discusses Palliative Care on OneNeurology Podcast Marking World Brain Day

      August 8, 2025

      Other News

      Empowering the HD Community: The Launch of the Huntington Academy

      July 10, 2025

      Advocacy

      EAN TV | National Brain Plans and the Path Toward EU Coordination: Insights from Finland and Europe

      June 21, 2025

      EAN Staff

      EAN Head Office Profiles: Ulla & Piyapat

      December 1, 2023

      EAN Staff

      EAN Head Office Profiles: Kathrin & Sasha

      August 28, 2023

      EAN Staff Anja Sander receiving flowers at the end of EAN Congress 2023

      Celebrating 20 Years of Excellence: Anja Sander, EAN’s Executive Director!

      August 3, 2023

      EAN Staff

      EAN Head Office Profiles: Dauren & Benita

      June 5, 2023

      EBC

      EAN TV | National Brain Plans and the Path Toward EU Coordination: Insights from Finland and Europe

      June 21, 2025

      EBC

      EAN TV | European Brain Council: Paving the Way for a European Brain Health Partnership

      June 21, 2025

      EBC Composite image containing various photos from European Brain Council events, plus the EBC logo

      EBC launches 2024 annual report

      April 25, 2025

      EBC

      Brain Innovation Days announces theme and subtheme for 2025 edition!

      March 29, 2025

      News in general

      New paper offers insight into patient involvement in neurological research 

      January 31, 2025

      News in general

      Join the European Brain Council’s ‘Towards a Rare Brain Disease Ecosystem’ event in Brussels on 20 February!

      January 31, 2025

      News in general

      The Brain Prize 2024: Pioneering work in computational and theoretical neuroscience is awarded the world’s largest brain research prize

      March 5, 2024

      News in general

      WHO’s Intersectoral Global Action Plan on epilepsy and other neurological disorders (IGAP) published in all six UN languages

      August 3, 2023

      Surveys

      Public Consultation – European Charter for the Responsible Development of Neurotechnologies

      November 25, 2024

      Surveys

      A survey on connectomics: key insights from EAN neurologists

      July 25, 2024

      Surveys

      Survey: Mapping European Neurological Programs in Solid Organ Transplant Centers

      May 31, 2024

      Surveys

      Neurorehabilitation Across Europe after Ischemic and Traumatic Brain Injuries: a survey to increase knowledge on brain-injury-specific neurorehabilitation

      July 14, 2023

  • EAN
  • Congress 2026
  • eanNews
  • eanCampus
  • Eur J Neurol
  • Brain Health Mission

eanNews

  • EAN News
    • All Executive Page President’s Corner EAN News EAN Congress news Interviews
      President’s Corner

      President’s Corner – October 2025

      October 8, 2025

      Research Highlights

      Research Highlights of the Month – October 2025

      October 7, 2025

      Paper of the Month

      Research Paper of the Month: AI-driven reclassification of multiple sclerosis progression

      October 6, 2025

      EAN News

      Join now for bonus months! Plus: October renewal discount and special benefit for associate members 

      October 1, 2025

      Executive Page

      Executive Page: New Opportunities and Resources to Strengthen EAN’s Scientific Community in 2025–2026

      September 4, 2025

      Executive Page

      Executive Page: the RRFS is here to support you – and help shape the future of European neurology

      August 12, 2025

      Executive Page

      Executive Page: thank you for making the EAN Congress 2025 a great success!

      July 16, 2025

      Executive Page

      Executive Page: Get ready for EAN 2025 in Helsinki!

      June 3, 2025

      President’s Corner

      President’s Corner – October 2025

      October 8, 2025

      President’s Corner

      President’s Corner – September 2025

      September 4, 2025

      President’s Corner

      President’s Corner – August 2025

      August 12, 2025

      President’s Corner

      President’s Corner – July 2025

      July 16, 2025

      EAN News

      President’s Corner – October 2025

      October 8, 2025

      EAN News

      Research Highlights of the Month – October 2025

      October 7, 2025

      EAN News

      Research Paper of the Month: AI-driven reclassification of multiple sclerosis progression

      October 6, 2025

      EAN News

      Join now for bonus months! Plus: October renewal discount and special benefit for associate members 

      October 1, 2025

      EAN Congress news

      EAN Associate Members get access to EAN Congress 2025 content for October!

      September 26, 2025

      EAN Congress news

      Save the Dates: EAN Congress 2026 in Geneva, Switzerland, 27-30 June

      September 10, 2025

      EAN Congress news

      An EAN Student Member’s experience at the EAN Congress – Helsinki 2025

      September 1, 2025

      EAN Congress news

      A Congress Highlight in Helsinki: Brain Health and Sustainability Booth

      August 28, 2025

      Interviews

      Video Interview: Mood Alterations in the Prodromal Phase of Sporadic Creutzfeldt-Jakob Disease, with Raphael Wurm

      March 14, 2025

      Interviews

      Video Interview: EMA approval of lecanemab, with Sebastiaan Engelborghs, EAN Dementia Panel Co-Chair

      January 15, 2025

      Interviews

      Video interview: Claudia Sommer, incoming Editor-in-Chief of the European Journal of Neurology

      January 3, 2025

      Interviews

      Video interviews: meet some of the EAN’s national neurological society partners!

      November 20, 2024

  • Research
    • All Paper of the Month Research Highlights Research Funding
      Research

      EMA Neurology News – September 2025

      October 8, 2025

      Research Highlights

      Research Highlights of the Month – October 2025

      October 7, 2025

      Paper of the Month

      Research Paper of the Month: AI-driven reclassification of multiple sclerosis progression

      October 6, 2025

      Research Highlights

      Research Highlights of the Month – September 2025

      September 10, 2025

      Paper of the Month

      Research Paper of the Month: AI-driven reclassification of multiple sclerosis progression

      October 6, 2025

      Paper of the Month

      Research Paper of the Month: Lithium deficiency and the onset of Alzheimer’s disease

      September 4, 2025

      Paper of the Month

      Research Paper of the Month: Higher Educational Attainment and Accelerated Tau Accumulation in Alzheimer Disease

      August 12, 2025

      Paper of the Month

      Research Paper of the Month: Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation (CATALYST)

      July 16, 2025

      Research Highlights

      Research Highlights of the Month – October 2025

      October 7, 2025

      Research Highlights

      Research Highlights of the Month – September 2025

      September 10, 2025

      Research Highlights

      Research Highlights of the Month – August 2025

      August 12, 2025

      Research Highlights

      Research Highlights of the Month – July 2025

      July 16, 2025

      Research Funding

      Draft Innovative Health Initiative (IHI) Funding Call topics related to the brain

      May 2, 2025

      Research Funding 'Horizon Europe' in large 3D text, surrounded by illustrations of people undertaking various activities

      Upcoming Horizon Europe Funding Opportunities for Neurology Researchers (Draft Calls)

      May 2, 2025

  • Education
    • All eLearning Mid-Career Resident and Research Fellows Student Corner Fellowship reports
      eLearning

      More webinars and brand-new episodes of eanCast: Weekly Neurology in October!

      October 7, 2025

      eLearning

      Join us for all-new Webinars in September!

      September 2, 2025

      EAN Congress news

      An EAN Student Member’s experience at the EAN Congress – Helsinki 2025

      September 1, 2025

      EAN News

      Shape the Future of EAN Panels – Apply to Join a Panel Management Group!

      September 1, 2025

      eLearning

      More webinars and brand-new episodes of eanCast: Weekly Neurology in October!

      October 7, 2025

      eLearning

      Join us for all-new Webinars in September!

      September 2, 2025

      eLearning

      Join our Webinar on New challenges in Myasthenia Gravis in the Era of Innovative Treatments

      August 28, 2025

      eLearning

      Join our Webinar on Multidisciplinary Perspectives on aTTR Amyloidosis: From Nerves to Heart

      August 21, 2025

      Mid-Career

      Certificate of Advanced Studies (CAS) in Brain Health starts second round in January 2026

      August 25, 2025

      Mid-Career

      First 20 EAN Leadership Programme participants graduate, as second group gets underway

      July 10, 2025

      Mid-Career

      Empowering growth: my journey through the EAN Leadership Programme

      March 14, 2025

      Mid-Career

      Join the EAN Congress Masterclass in Vienna!

      January 20, 2025

      Resident and Research Fellows

      Shape the Future of EAN Panels – Apply to Join a Panel Management Group!

      September 1, 2025

      Resident and Research Fellows

      Sign up for the 5th EAN Science School, 13-17 March, 2026

      August 20, 2025

      Resident and Research Fellows

      EAN Regional Teaching Day in Riga, Latvia – 6 November 2025

      August 13, 2025

      Resident and Research Fellows

      Executive Page: the RRFS is here to support you – and help shape the future of European neurology

      August 12, 2025

      Student Corner

      An EAN Student Member’s experience at the EAN Congress – Helsinki 2025

      September 1, 2025

      Student Corner

      Student Teaser Fellowships winners 2025

      June 6, 2025

      Student Corner Photo of a sheet of paper, pencil and crumpled paper on a desk.

      Why Neurology? Read some compelling answers from our EAN 2025 essay contest winners!

      May 12, 2025

      Student Corner

      Student Teaser Fellowship reports 2023 – Paris & Basel

      March 12, 2025

      Fellowship reports

      Research Fellowship Reports 2023: Lyon, Berlin, & London

      March 31, 2025

      Fellowship reports

      Student Teaser Fellowship reports 2023 – Paris & Basel

      March 12, 2025

      Fellowship reports

      Clinical Fellowship Reports 2023: Utrecht, Dianalund, & London

      February 20, 2025

      Fellowship reports

      Research Fellowship Reports 2023: London & Vienna/Paris

      October 8, 2024

  • Other News
    • All EAN Staff EBC News in general Surveys
      Advocacy

      Why do Placebo and Nocebo Effects Matter? – Improving the Education of Healthcare Professionals | 5 November 2025

      August 21, 2025

      Other News

      EAN Panel Management Group Member Discusses Palliative Care on OneNeurology Podcast Marking World Brain Day

      August 8, 2025

      Other News

      Empowering the HD Community: The Launch of the Huntington Academy

      July 10, 2025

      Advocacy

      EAN TV | National Brain Plans and the Path Toward EU Coordination: Insights from Finland and Europe

      June 21, 2025

      EAN Staff

      EAN Head Office Profiles: Ulla & Piyapat

      December 1, 2023

      EAN Staff

      EAN Head Office Profiles: Kathrin & Sasha

      August 28, 2023

      EAN Staff Anja Sander receiving flowers at the end of EAN Congress 2023

      Celebrating 20 Years of Excellence: Anja Sander, EAN’s Executive Director!

      August 3, 2023

      EAN Staff

      EAN Head Office Profiles: Dauren & Benita

      June 5, 2023

      EBC

      EAN TV | National Brain Plans and the Path Toward EU Coordination: Insights from Finland and Europe

      June 21, 2025

      EBC

      EAN TV | European Brain Council: Paving the Way for a European Brain Health Partnership

      June 21, 2025

      EBC Composite image containing various photos from European Brain Council events, plus the EBC logo

      EBC launches 2024 annual report

      April 25, 2025

      EBC

      Brain Innovation Days announces theme and subtheme for 2025 edition!

      March 29, 2025

      News in general

      New paper offers insight into patient involvement in neurological research 

      January 31, 2025

      News in general

      Join the European Brain Council’s ‘Towards a Rare Brain Disease Ecosystem’ event in Brussels on 20 February!

      January 31, 2025

      News in general

      The Brain Prize 2024: Pioneering work in computational and theoretical neuroscience is awarded the world’s largest brain research prize

      March 5, 2024

      News in general

      WHO’s Intersectoral Global Action Plan on epilepsy and other neurological disorders (IGAP) published in all six UN languages

      August 3, 2023

      Surveys

      Public Consultation – European Charter for the Responsible Development of Neurotechnologies

      November 25, 2024

      Surveys

      A survey on connectomics: key insights from EAN neurologists

      July 25, 2024

      Surveys

      Survey: Mapping European Neurological Programs in Solid Organ Transplant Centers

      May 31, 2024

      Surveys

      Neurorehabilitation Across Europe after Ischemic and Traumatic Brain Injuries: a survey to increase knowledge on brain-injury-specific neurorehabilitation

      July 14, 2023

Breaking newsCOVID-19

COVID-19 Breaking News: Observational studies – prospective longitudinal cohort

January 10, 2022

Observational studies: prospective longitudinal cohort (Green)

Read on for our highlighted selection of Covid-related obeservational studies from the scientific press for January 2022:

  • Disorders of Consciousness Associated With COVID-19: A Prospective, Multimodal Study of Recovery and Brain Connectivity
  • Recovery From COVID-19 in Multiple Sclerosis A Prospective and Longitudinal Cohort Study of the United Kingdom Multiple Sclerosis Register
  • Cognitive sequelae of long COVID may not be permanent. A prospective study
  • Interferon Beta-1a treatment promotes SARS-CoV-2 mRNA vaccine response in multiple sclerosis subjects

Disorders of Consciousness Associated With COVID-19: A Prospective, Multimodal Study of Recovery and Brain Connectivity
In patients with severe coronavirus disease 2019 (COVID-19), disorders of consciousness (COVID-DoC) have emerged as a serious complication. The prognosis and pathophysiology of COVID-DoC remain unclear, complicating decisions about continuing life-sustaining treatment. In this prospective, longitudinal study the authors describe the natural history of COVID-DoC and investigate its associated brain connectivity profile. They screened consecutive patients with COVID-19 and enrolled critically ill adult patients with a DoC unexplained by sedation or structural brain injury, and who were planned to undergo a brain MRI. They performed resting state functional MRI and diffusion MRI to evaluate functional and structural connectivity, as compared to healthy controls and patients with DoC resulting from severe traumatic brain injury (TBI). they assessed the recovery of consciousness (command-following) and functional outcomes (Glasgow Outcome Scale Extended [GOSE] and the Disability Rating Scale [DRS]) at hospital discharge, three months post-discharge, and six months post-discharge. They also explored whether clinical variables were associated with recovery from COVID-DoC. After screening 1,105 patients with COVID-19, the authors enrolled twelve with COVID-DoC. The median age was 63.5 years [interquartile range 55-76.3]. Excluding one who died shortly after enrollment, all of the remaining eleven patients recovered consciousness, after 0-25 days (median 7 [5-14.5]) following the cessation of continuous intravenous sedation. At discharge, all surviving patients remained dependent – median GOSE 3 [1-3], median DRS 23 [16-30]. However ultimately, except for two patients with severe polyneuropathy, all returned home with normal cognition and minimal disability – at three months, median GOSE 3 [3-3], median DRS 7 [5-13]; at six months, median GOSE 4 [4-5], median DRS 3 [3-5]. Ten patients with COVID-DoC underwent advanced neuroimaging; functional and structural brain connectivity in COVID-DoC was diminished compared to healthy controls, and structural connectivity was comparable to patients with severe TBI. The authors concluded that patients who survived invariably recovered consciousness after COVID-DoC. Though disability was common following hospitalization, functional status improved over the ensuing months.
David Fischer, Samuel B Snider, Megan E Barra, William R Sanders, Otto Rapalino, Pamela Schaefer, Andrea S. Foulkes, Yelena G Bodien, Brian L Edlow. Disorders of Consciousness Associated With COVID-19: A Prospective, Multimodal Study of Recovery and Brain Connectivity. Neurology Dec 2021, 10.1212/WNL.0000000000013067; DOI: 10.1212/WNL.0000000000013067.


Recovery From COVID-19 in Multiple Sclerosis A Prospective and Longitudinal Cohort Study of the United Kingdom Multiple Sclerosis Register
The objective of this study was to understand the course of recovery from coronavirus disease 2019 (COVID-19) among patients with multiple sclerosis (MS) and to determine its predictors, including patients’ pre–COVID-19 physical and mental health status. This prospective and longitudinal cohort study recruited patients with MS who reported COVID-19 from March 17, 2020, to March 19, 2021, as part of the United Kingdom MS Register (UKMSR) COVID-19 study. Participants used online questionnaires to regularly update their COVID-19 symptoms, recovery status, and duration of symptoms for those who fully recovered. Questionnaires were date stamped for estimation of COVID-19 symptom duration for those who had not recovered at their last follow-up. The UKMSR holds demographic and up-to-date clinical data on participants as well as their web-based Expanded Disability Status Scale (web-EDSS) and Hospital Anxiety and Depression Scale (HADS) scores. The association between these factors and recovery from COVID-19 was assessed using multivariable Cox regression analysis. Of the 7,977 patients with MS who participated in the UKMSR COVID-19 study, 599 reported COVID-19 and prospectively updated their recovery status. Twenty-eight hospitalized participants were excluded. At least 165 participants (29.7%) had long-standing COVID-19 symptoms for ≥4 weeks and 69 (12.4%) for ≥12 weeks. Participants with pre–COVID-19 web-EDSS scores ≥7, participants with probable anxiety and/or depression (HADS scores ≥11) before COVID-19 onset, and women were less likely to report recovery from COVID-19. The authors concluded that patients with MS are affected by postacute sequelae of COVID-19. Preexisting severe neurologic impairment or mental health problems appear to increase this risk. These findings can have implications in tailoring their post–COVID-19 rehabilitation.
Garjani A, Middleton RM, Nicholas R, Evangelou N. Recovery From COVID-19 in Multiple Sclerosis: A Prospective and Longitudinal Cohort Study of the United Kingdom Multiple Sclerosis Register. Neurol Neuroimmunol Neuroinflamm. 2021 Nov 30;9(1):e1118. doi: 10.1212/NXI.0000000000001118.


Cognitive sequelae of long COVID may not be permanent. A prospective study
Cognitive decline is a recognized manifestation of long COVID, even among patients who experienced mild disease. However, there is no evidence regarding the length of cognitive decline in these patients. This study aimed to assess whether COVID-19-related cognitive decline is a permanent deficit or if it improves over time. Cognitive performance was evaluated by means of the Montreal Cognitive Assessment (MoCA) in COVID-19 survivors and non-infected individuals. All study participants had four cognitive evaluations, two of them before the pandemic and the other two, six and 18 months after the initial SARS-CoV-2 outbreak infection in the village. Linear mixed effects models for longitudinal data were fitted to assess differences in cognitive performance across COVID-19 survivors and non-infected individuals. The study included 78 participants, 50 with history of mild COVID-19 and 28 without. There was a significant – likely age-related – decline in MoCA scores between the two pre-pandemic tests (β: -1.53; 95% C.I.: -2.14 to -0.92; p<0.001), which did not differ across individuals who later developed COVID-19 when compared to non-infected individuals. Six months after infection, only COVID-19 survivors had a significant decline in MoCA scores (β: -1.37; 95% C.I.: -2.14 to -0.61; p<0.001), which reversed after one additional year of follow-up (β: 0.66; 95% C.I.: -0.11 to 1.42; p=0.092). No differences were noticed among non-infected individuals when both post-pandemic MoCA scores were compared. The authors concluded that this study results suggest that long COVID-related cognitive decline may spontaneously improve over time.
Del Brutto OH, Rumbea DA, Recalde BY, Mera RM. Cognitive sequelae of long COVID may not be permanent. A prospective study. Eur J Neurol. 2021 Dec 16. doi: 10.1111/ene.15215.


Interferon Beta-1a treatment promotes SARS-CoV-2 mRNA vaccine response in multiple sclerosis subjects
Several concerns exist on the immunogenicity of SARS-CoV-2 vaccines in multiple sclerosis (MS) subjects due to their immunomodulating disease modifying therapies (DMTs). Here the authors report a comparison of the humoral response to BNT162b2-mRNA coronavirus (COVID)-19 vaccine and the immunological phenotype in a cohort of 125 MS subjects undergoing different DMTs, with no history of SARS-CoV-2 infection. They collected serum and blood samples at the first day of vaccine (T0) and 21 days after the second vaccine dose (T1) from 125 MS subjects, undergoing eight different DMTs. Sera were tested using the Elecsys anti-SARS-CoV-2-IgG assay for the detection of IgG antibodies to SARS-CoV-2 spike protein. The anti-spike IgG titres from MS subjects were compared with 24 age- and sex-matched healthy controls (HC). Percentage and absolute number of B and T lymphocytes were evaluated by cytofluorimetric analysis in the same study cohort. When compared with SARS-CoV-2 IgG levels in HC (n = 24, median 1089 (IQR 652.5-1625) U/mL), the authors observed an increased secretion of SARS-CoV-2 IgG in interferon-beta 1a (IFN)-treated MS subjects (n = 22, median 1916 (IQR 1024-2879) U/mL) and an impaired humoral response in MS subjects undergoing cladribine (CLAD) (n = 10, median 396.9 (IQR 37.52-790.9) U/mL), fingolimod (FTY) (n = 19, median 7.9 (IQR 4.8-147.6) U/mL) and ocrelizumab (OCRE) (n = 15, median 0.67 (IQR 0.4-5.9) U/mL) treatment. Moreover, analysis of geometric mean titre ratio (GMTR) between different DMT’s groups of MS subjects revealed that, when compared with IFN-treated MS subjects, intrinsic antibody production was impaired in teriflunomide (TERI)-, natalizumab (NAT)-, CLAD-, FTY- and OCRE-, while preserved in DMF- and GA-treated MS subjects. The authors concluded that humoral response to BNT162b2-mRNA-vaccine was increased in IFN-treated MS subjects while clearly blunted in those under CLAD, FTY and OCRE treatment. This suggests that the DMTs could have a key role in the protection from SARS-CoV-2 related disease and complication in MS subjects, underlying a novel aspect that should be considered in the selection of the most appropriate therapy under COVID-19 pandemic.
Maniscalco GT, Manzo V, Ferrara AL, Perrella A, Di Battista M, Salvatore S, Graziano D, Viola A, Amato G, Moreggia O, Di Giulio Cesare D, Barbato S, Servillo G, Longo K, Di Giovanni M, Scarpati B, Muggianu SM, Longo G, Russo G, Andreone V, De Rosa V. Interferon Beta-1a treatment promotes SARS-CoV-2 mRNA vaccine response in multiple sclerosis subjects. Mult Scler Relat Disord. 2021 Dec 18;58:103455. doi: 10.1016/j.msard.2021.103455.


COVID-19 Breaking News: Observational studies – prospective longitudinal cohort was last modified: January 11th, 2022 by Simon Lee
Share this...
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
Linkedin
previous post
COVID-19 Breaking News: Cross-Sectional Case Control Studies (Part 2)
next post
COVID-19 Breaking News: Interventional Studies with open label/non-randomised methodology

You may also like

COVID-19 Research Round-Up: Literature reviews – April 2023

April 26, 2023

COVID-19 Research Round-Up: Cross-Sectional Case Control Studies – April 2023

April 26, 2023

COVID-19 Research Round-Up: Case Series/Case Reports – April 2023

April 26, 2023

COVID-19 Research Round-Up: Literature reviews – March 2023

March 16, 2023

COVID-19 Research Round-Up: Cross-Sectional Case Control Studies – March 2023

March 16, 2023

COVID-19 Research Round-Up: Case Series/Case Reports – March 2023

March 16, 2023

COVID-19 Research Round-Up: Meta-analyses/systematic reviews – March 2023

March 16, 2023

COVID-19 and neurology: a survey of previous and continued restrictions on clinical practice, professional education and neuroeconomics

March 3, 2023

COVID-19 Research Round-Up: Cross-Sectional Case Control Studies – February 2023

February 13, 2023

COVID-19 Research Round-Up: Case Series/Case Reports – February 2023

February 13, 2023

Upcoming Events

Oct
2
Thu
all-day GNP Annual Conference 2025
GNP Annual Conference 2025
Oct 2 2025 – Oct 5 2026 all-day
GNP Annual Conference 2025
  The GNP Annual conference will take place in the Kursaal Bern, in the heart of the city with a view of the old town and the mountains. You can expect…
Oct
5
Sun
all-day 25th World Congress of Psychiatr...
25th World Congress of Psychiatr...
Oct 5 – Oct 8 all-day
25th World Congress of Psychiatry (WCP 25)
  World Congress of Psychiatry  will take place from October 5-8, 2025 in the enchanting city of Prague, Czech Republic. Be among the first to hear cutting-edge insights from experts,…
all-day Annual International Congress of...
Annual International Congress of...
Oct 5 – Oct 9 all-day
Annual International Congress of Parkinson's Disease and Movement Disorders
  Join thousands of professionals to share ideas and advance the clinical and scientific discipline of Movement Disorders. The annual International Congress of Parkinson’s Disease and Movement Disorders® gathers leading…
all-day EANS 2025 Annual Congress
EANS 2025 Annual Congress
Oct 5 – Oct 9 all-day
EANS 2025 Annual Congress
  The European Association of Neurosurgical Societies (EANS) is pleased to announce that its annual Congress will take place in October 2025 in Vienna, Austria. The theme of EANS2025 will…
all-day The 17th International Congress ...
The 17th International Congress ...
Oct 5 – Oct 8 all-day
The 17th International Congress of Neuroimmunology and the 5th Global Schools of Neuroimmunology
  ISNI 17-th Congress will be hosted in Japan from 5- 8  October 2025. Following the COVID-19 pandemic, daily life and academic engagement have changed significantly. ISNI  aims to revive…
View Calendar

Keep in touch

Bluesky Facebook Instagram LinkedIn
eanNews is a members service of the European Academy of Neurology https://www.ean.org

All content from January 2012 - June 2013 was published by EFNS; content from July 2013 - June 2014 by EFNS and ENS.

ISSN 2310-2934

Keep in touch

Bluesky Facebook Instagram LinkedIn

Archives

Pages

  • Privacy Policy
  • About us
  • Help

Back To Top